1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Insulin Resistance Global Clinical Trials Review, H1, 2014

Insulin Resistance Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Insulin Resistance Global Clinical Trials Review, H1, 2014" provides data on the Insulin Resistance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insulin Resistance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Insulin Resistance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Insulin Resistance Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Insulin Resistance 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Insulin Resistance 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Insulin Resistance Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Insulin Resistance 35
Oct 19, 2011: Genfit Announces Hospital-Based Clinical Study Demonstrates Action Of GFT505 On Liver 35
Aug 19, 2010: Limerick BioPharma Announces Positive Phase 1b Data for LIM-0705 in Preventing 35
Toxicities Associated with the Transplant Drug, Tacrolimus. 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Merck and Co., Inc. 37
Clinical Trial Overview of Merck and Co., Inc. 37
Bristol-Myers Squibb Company 38
Clinical Trial Overview of Bristol-Myers Squibb Company 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Royal DSM N.V. 41
Clinical Trial Overview of Royal DSM N.V. 41
Genfit SA 42
Clinical Trial Overview of Genfit SA 42
Harbor Diversified, Inc. 43
Clinical Trial Overview of Harbor Diversified, Inc. 43
F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44
E. I. du Pont de Nemours and Company 45
Clinical Trial Overview of E. I. du Pont de Nemours and Company 45
Clinical Trial Overview of Top Institutes / Government 46
The National Institute of Diabetes and Digestive and Kidney Diseases 46
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46
National Heart, Lung, and Blood Institute 47
Clinical Trial Overview of National Heart, Lung, and Blood Institute 47
Stanford University 48
Clinical Trial Overview of Stanford University 48
Academic Medical Center 49
Clinical Trial Overview of Academic Medical Center 49
Mayo Clinic 50
Clinical Trial Overview of Mayo Clinic 50
Vanderbilt University 51
Clinical Trial Overview of Vanderbilt University 51
Aarhus University 52
Clinical Trial Overview of Aarhus University 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Maastricht University Medical Center 54
Clinical Trial Overview of Maastricht University Medical Center 54
Massachusetts General Hospital 55
Clinical Trial Overview of Massachusetts General Hospital 55
Five Key Clinical Profiles 56
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77

List of Tables
Insulin Resistance Therapeutics, Global, Clinical Trials by Region, 2014* 7
Insulin Resistance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Insulin Resistance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Insulin Resistance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Insulin Resistance Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Insulin Resistance Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Insulin Resistance Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Insulin Resistance Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Insulin Resistance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Insulin Resistance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Insulin Resistance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Insulin Resistance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Insulin Resistance Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Insulin Resistance Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Insulin Resistance Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Insulin Resistance Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Insulin Resistance Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Insulin Resistance Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Insulin Resistance Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Insulin Resistance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Insulin Resistance Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Insulin Resistance Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Insulin Resistance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Insulin Resistance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 37
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 38
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 39
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 40
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal DSM N.V., 2014* 41
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014* 42
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Harbor Diversified, Inc., 2014* 43
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 44
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by E. I. du Pont de Nemours and Company, 2014* 45
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 46
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 47
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 48
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 49
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 50
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 51
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 52
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 53
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 54
Insulin Resistance Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 55

List of Figures
Insulin Resistance Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Insulin Resistance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Insulin Resistance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Insulin Resistance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Insulin Resistance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Insulin Resistance Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Insulin Resistance Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Insulin Resistance Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Insulin Resistance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Insulin Resistance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Insulin Resistance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Insulin Resistance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Insulin Resistance Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Insulin Resistance Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Insulin Resistance Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Insulin Resistance Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Insulin Resistance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Insulin Resistance Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Insulin Resistance Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Insulin Resistance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Insulin Resistance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Type 2 Diabetes Mellitus: KOL Insight 2016

Type 2 Diabetes Mellitus: KOL Insight 2016

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Can top-ranked GLP1 agonists move out of the third-line setting? GLP1 agonists may be the top-ranked type 2 diabetes mellitus (T2DM) treatment according to the American Association of Clinical Endocrinologists ...

European Market Report for Modern Insulin 2016 - MedCore

European Market Report for Modern Insulin 2016 - MedCore

  • $ 5995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern ...

US Market Report for Insulin 2017 - MedCore

US Market Report for Insulin 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. insulin market can be segmented by insulin type, yielding four segments: long-acting insulin, rapid-acting insulin, premixed insulin and human insulin. In 2016, the largest segment ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in New Zealand - Forecast

  • December 2016
    71 pages
  • Therapy  

  • New Zealand  

View report >

Insulin Market in the US

  • December 2016
    8 pages
  • Insulin  

  • United States  

View report >

Therapy Market in the UK

  • December 2016
    194 pages
  • Therapy  

    Infectious Dise...  

    Eye Disease  

  • United Kingdom  

View report >

Related Market Segments :

Insulin
Therapy
Clinical Trial

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.